SCHEMBL50126

SCHEMBL50126

CCCCCCCC(=O)O[C@H]1CO[C@H]2[C@@H]1OC[C@H]2OC(=O)CCCCCCC

nearest known ligand 0.56

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
BCHE P06276 4/20 0.56
NAAA Q02083 2/20 0.54
PRKCA P17252 6/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL227921 1.00 BCHE (0.56) BCHENAAAPRKCA
SCHEMBL15073363 1.00 BCHE (0.56) BCHENAAAPRKCA
SCHEMBL15073365 1.00 BCHE (0.56) BCHENAAAPRKCA
SCHEMBL7000758 1.00 BCHE (0.56) BCHENAAAPRKCA
SCHEMBL15073362 1.00 BCHE (0.56) BCHENAAAPRKCA
SCHEMBL16681731 1.00 BCHE (0.56) BCHENAAAPRKCA
SCHEMBL16752819 1.00 BCHE (0.56) BCHENAAAPRKCA
SCHEMBL20213354 1.00 BCHE (0.56) BCHENAAAPRKCA
SCHEMBL16681688 1.00 BCHE (0.56) BCHENAAAPRKCA
SCHEMBL230317 1.00 BCHE (0.56) BCHENAAAPRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 197 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4746847-A2 COMPOSITION & METHODS FOR REGULATING MELANOGENESIS Sytheon Ltd. (US) 2026-05-27 EP claimed
EP-4746865-A1 NOVEL AMINO ACID BASED SALTS, COMPOSITIONS AND METHODS FOR TREATING SKIN AND REJUVENATING SKIN AND EXTENDING LONGEVITY Sytheon Ltd. (US) 2026-05-27 EP claimed
US-20260041620-A1 NOVEL AMINO ACID BASED SALTS, COMPOSITIONS AND METHODS FOR TREATING SKIN AND IMPROVING SKIN REJUVENATION AND LONGEVITY SYTHEON LTD (US) 2026-02-12 US claimed
WO-2025264728-A1 COSMETIC COMPOSITIONS AND METHODS OF MOISTURIZING SKIN ROC OPCO LLC (US) 2025-12-26 WO claimed
US-20250360064-A1 COMPOSITIONS AND METHODS FOR MOISTURIZING A SKIN REGION JAMRM LLC (US) 2025-11-27 US claimed
US-20250099355-A1 AMINO ACID BASED SALTS, COMPOSITIONS AND METHODS FOR TREATING SKIN AND IMPROVING SKIN REJUVENATION AND LONGEVITY SYTHEON LTD (US) 2025-03-27 US claimed
WO-2025019570-A1 NOVEL AMINO ACID BASED SALTS, COMPOSITIONS AND METHODS FOR TREATING SKIN AND REJUVENATING SKIN AND EXTENDING LONGEVITY SYTHEON LTD. (US) 2025-01-23 WO claimed
WO-2025019573-A2 COMPOSITION & METHODS FOR REGULATING MELANOGENESIS SYTHEON LTD. (US) 2025-01-23 WO claimed
US-12171852-B1 Composition and methods for regulating melanogenesis SYTHEON LTD (US) 2024-12-24 US claimed
WO-2024163939-A1 COMPOSITIONS AND METHODS FOR MOISTURIZING A SKIN REGION JAMRM, LLC (US) 2024-08-08 WO claimed
EP-4103142-A1 COMPOSITIONS COMPRISING LIPOPHILIC COMPOUNDS AND ONE OR MORE (BIO)-ALKANEDIOLS Symrise AG (DE) 2022-12-21 EP claimed
CN-114133298-B One-time fertilization and industrial seedling raising method for rice 江苏省农业科学院 2022-11-04 CN claimed
US-11458082-B1 Tanning compositions including dihydroxyacetone Curb Appeal Beauty LLC (US) 2022-10-04 US claimed
WO-2022122885-A1 COMPOSITIONS COMPRISING LIPOPHILIC COMPOUNDS AND ONE OR MORE (BIO)-ALKANEDIOLS SYMRISE AG (DE) 2022-06-16 WO claimed
WO-2022122131-A1 COMPOSITIONS COMPRISING LIPOPHILIC COMPOUNDS AND ONE OR MORE (BIO)-ALKANEDIOLS SYMRISE AG (DE) 2022-06-16 WO claimed
EP-2588073-B1 COSMETIC COMPOSITION FOR THE NAILS AND USE OF AN ISOSORBIDE DERIVATIVE FIABILA (FR) 2017-06-14 EP claimed
US-9180317-B2 Cosmetic composition for nails and the use of an isosorbide derivative FIABILA (FR) 2015-11-10 US claimed
EP-2531565-A1 DIANHYDROHEXITOL DIESTER COALESCING AGENT Elementis Specialties, Inc. (US) 2012-12-12 EP claimed
US-20120003166-A1 COSMETIC COMPOSITION FOR NAILS AND THE USE OF AN ISOSORBIDE DERIVATIVE FIABILA (FR) 2012-01-05 US claimed
WO-2011097443-A1 DIANHYDROHEXITOL DIESTER COALESCING AGENT ELEMENTIS SPECIALTIES,INC (US) 2011-08-11 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250099355-A1 AMINO ACID BASED SALTS, COMPOSITIONS AND METHODS FOR TREATING SKIN AND IMPROVING SKIN REJUVENATION AND LONGEVITY AADAT, BCAT2, BCAT1 BCHE 1006/4885NAAA 517/4885PRKCA 330/4885
US-20260041620-A1 NOVEL AMINO ACID BASED SALTS, COMPOSITIONS AND METHODS FOR TREATING SKIN AND IMPROVING SKIN REJUVENATION AND LONGEVITY TYR, ARG2, BCAT2 BCHE 346/4885NAAA 1646/4885PRKCA 799/4885
US-20120003166-A1 COSMETIC COMPOSITION FOR NAILS AND THE USE OF AN ISOSORBIDE DERIVATIVE DPM1, POLR1C, SORD BCHE 4389/4885NAAA 4554/4885PRKCA 2444/4885
US-12171852-B1 Composition and methods for regulating melanogenesis TYR, MITF, MC1R BCHE 1800/4885NAAA 1223/4885PRKCA 574/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.